N Engl J Med. 2003 Dec 18;349(25):2379-80.

Systemic lupus erythematosus and accelerated atherosclerosis.

Hahn BH.

Source

David Geffen School of Medicine at the University of California Los Angeles, Los Angeles, USA.

Comment in

Premature coronary disease in systemic lupus. [N Engl J Med. 2004]
Premature coronary disease in systemic lupus.Violi F, Loffredo L, Ferro D. N Engl J Med. 2004 Apr 8; 350(15):1571-5; author reply 1571-5.
Premature coronary disease in systemic lupus. [N Engl J Med. 2004]
Premature coronary disease in systemic lupus.Noël B. N Engl J Med. 2004 Apr 8; 350(15):1571-5; author reply 1571-5.

Comment on

Prevalence and correlates of accelerated atherosclerosis in systemic lupus erythematosus. [N Engl J Med. 2003]
Prevalence and correlates of accelerated atherosclerosis in systemic lupus erythematosus.Roman MJ, Shanker BA, Davis A, Lockshin MD, Sammaritano L, Simantov R, Crow MK, Schwartz JE, Paget SA, Devereux RB, et al. N Engl J Med. 2003 Dec 18; 349(25):2399-406.
Premature coronary-artery atherosclerosis in systemic lupus erythematosus. [N Engl J Med. 2003]
Premature coronary-artery atherosclerosis in systemic lupus erythematosus.Asanuma Y, Oeser A, Shintani AK, Turner E, Olsen N, Fazio S, Linton MF, Raggi P, Stein CM. N Engl J Med. 2003 Dec 18; 349(25):2407-15.

PMID:: 14681501; [PubMed - indexed for MEDLINE]

LinkOut - more resources

Full Text Sources

Medical

Lupus - MedlinePlus Health Information

Molecular Biology Databases

CYCLOPHOSPHAMIDE - HSDB

Supplemental Content

Save items

Related citations in PubMed

Prevalence and correlates of accelerated atherosclerosis in systemic lupus erythematosus. [N Engl J Med. 2003]
Prevalence and correlates of accelerated atherosclerosis in systemic lupus erythematosus.
Roman MJ, Shanker BA, Davis A, Lockshin MD, Sammaritano L, Simantov R, Crow MK, Schwartz JE, Paget SA, Devereux RB, et al. N Engl J Med. 2003 Dec 18; 349(25):2399-406.
Premature atherosclerosis-related central nervous system involvement in two cases of systemic lupus erythematosus. [J Clin Rheumatol. 2007]
Premature atherosclerosis-related central nervous system involvement in two cases of systemic lupus erythematosus.
Zhang X, Tian X, Zhang F. J Clin Rheumatol. 2007 Aug; 13(4):211-2.
Accelerated atherosclerosis in systemic lupus erythematosus: perspectives towards decreasing cardiovascular morbidity and mortality. [Lupus. 2009]
Accelerated atherosclerosis in systemic lupus erythematosus: perspectives towards decreasing cardiovascular morbidity and mortality.
Escárcega RO, Garcia-Carrasco M, Jara LJ, Cervera R. Lupus. 2009 Apr; 18(5):383-6.
Review Atheroma and systemic lupus erythematosus. [Joint Bone Spine. 2007]
Review Atheroma and systemic lupus erythematosus.
Soubrier M, Mathieu S, Dubost JJ. Joint Bone Spine. 2007 Dec; 74(6):566-70. Epub 2007 Jul 19.
Review [Risk of atherosclerosis development in patients with systemic lupus erythematosus]. [Pol Arch Med Wewn. 2005]
Review [Risk of atherosclerosis development in patients with systemic lupus erythematosus].
Kotyla PJ, Sliwińska-Kotyla B, Lewicki M, Kucharz EJ. Pol Arch Med Wewn. 2005 Nov; 114(5):1138-43.

See reviews... See all...

Cited by 8 PubMed Central articles

Manifestations of systemic lupus erythematosus. [Maedica (Buchar). 2011]
Manifestations of systemic lupus erythematosus.
Cojocaru M, Cojocaru IM, Silosi I, Vrabie CD. Maedica (Buchar). 2011 Oct; 6(4):330-6.
Review HDAC inhibition in lupus models. [Mol Med. 2011]
Review HDAC inhibition in lupus models.
Reilly CM, Regna N, Mishra N. Mol Med. 2011 May-Jun; 17(5-6):417-25. Epub 2011 Feb 11.
Selective cyclooxygenase-2 inhibitor suppresses renal thromboxane production but not proliferative lesions in the MRL/lpr murine model of lupus nephritis. [Am J Med Sci. 2011]
Selective cyclooxygenase-2 inhibitor suppresses renal thromboxane production but not proliferative lesions in the MRL/lpr murine model of lupus nephritis.
Oates JC, Halushka PV, Hutchison FN, Ruiz P, Gilkeson GS. Am J Med Sci. 2011 Feb; 341(2):101-5.

See all...

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Compound (MeSH Keyword)
PubChem chemical compound records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

Systemic lupus erythematosus and accelerated atherosclerosis.
Systemic lupus erythematosus and accelerated atherosclerosis.
N Engl J Med. 2003 Dec 18 ;349(25):2379-80.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to:

Systemic lupus erythematosus and accelerated atherosclerosis.

Source

Comment in

Comment on

Publication Types, MeSH Terms, Substances

Publication Types

MeSH Terms

Substances

LinkOut - more resources

Full Text Sources

Medical

Molecular Biology Databases

Supplemental Content

Save items

Related citations in PubMed

Cited by 8 PubMed Central articles

Related information

Recent activity

Simple NCBI Directory

Getting Started

Resources

Popular

Featured

NCBI Information